Previous close | 0.0000 |
Open | 0.5400 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.5400 - 0.5400 |
52-week range | 0.5400 - 0.5400 |
Volume | |
Avg. volume | N/A |
Market cap | 190,961 |
Beta (5Y monthly) | 1.17 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.2830 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
DGAP-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement/Quarter ResultsEpigenomics AG Reports Financial Results for the First Quarter of 2022 11.05.2022 / 08:00 The issuer is solely responsible for the content of this announcement.Epigenomics AG Reports Financial Results for the First Quarter of 2022 Berlin (Germany) and San Diego, CA (U.S.A.), May 11, 2022 - Epigenomics AG (FSE: ECX, OTCQX: EPGNY, the "Company") today reported financial results (IFRS, unaudited) for the first thr
While still far below the all-time highs, Macy's, Inc. (NYSE: M) has rallied significantly from the 2020 lows. Yet, despite the improving fundamentals and reinstated dividend, the stock remains trading in a single-digit price-to-earnings (P/E) ratio.
Yahoo Finance's Jared Blikre examines the market action around the Dow and the S&P, in addition to looking at the retail sector and the EV space.